OCGN Q3 2025 Earnings — Ocugen, Inc. Revenue & Financial Results | Market Cap Arena

OCGNOcugen, Inc.

$578M

Q3 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M+54.2% YoY

Gross Profit

$2M100.0% margin

Operating Income

-$18M-1006.0% margin

Net Income

-$20M-1144.5% margin

EPS (Diluted)

$-0.07

QoQ Revenue Growth

+27.6%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$13M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$58M

Total Liabilities

$54M

Stockholders' Equity

$4M

Cash & Equivalents

$33M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$1M	+54.2%
Gross Profit	$2M	$1M	+54.2%
Operating Income	-$18M	-$13M	-33.0%
Net Income	-$20M	-$13M	-54.6%